Facial Cellulitis and Erysipelas with Cutaneous Portal of Entry: Five Cases in Brazzaville, Congo
DOI:
https://doi.org/10.12970/2310-998X.2019.07.01Keywords:
Dermohypodermitis, cellulitis, erysipelas, face, HIV.Abstract
Objectives: This study aimed to describe the clinical, therapeutic and evolutional features of facial cellulitis or erysipelas (CorE) with cutaneous entry portal.
Methods: It was a retrospective study, carried out from January 2016 to May 2019 including inpatients, aged 15 years or older, admitted for CorE with a cutaneous entry portal. Demographic, clinical and biological data were studied.
Results: Five patients were included and accounted for 3.12% of hospitalized cases for CorE. Three were erysipelas and two were cellulites. A previous history of CorE was not found. The entry portal was skin erosion due to herpesviruses infection in four cases and traumatic wound in one case. The systemic inflammatory response syndrome criteria were observed in all patients. Erysipelas was differentiated from cellulite by the clear demarcation of erythema. The other local aspects found were edema, bullae and purpuric lesions. HIV seropositivity was detected in four patients and one patient was diabetic. The antibiotic regimen was amoxicillin / clavulanic acid in 3 cases and ceftriaxone in 2 cases. Healing was obtained in all patients without sequelae of CorE. The mean hospital stay was 11 days.
Conclusion: Facial cellulite and erysipelas are two clinically distinct entities. The bacteriological diagnosis is still difficult and lead to the use of probabilistic antibiotic protocols. The specific risk factors for facial CorE are still unclear. These diseases require the search for comorbidity.
References
Bonnetblanc JM, Bédane C. Erysipelas. Recognition and Management. Am J Clin Dermatol 2003; 4(3): 157-63. https://doi.org/10.2165/00128071-200304030-00002
Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL, et al. Infectious Diseases Society of America. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis 2014; 59(2): e10-e52. https://doi.org/10.1093/cid/ciu296
O'Connor K, Paauw D. Erysipelas: rare but important cause of malar rash. Am J Med 2010; 123(5): 414-6. https://doi.org/10.1016/j.amjmed.2009.09.036
Rath E, Skrede S, Mylvaganam H, Bruun T. Aetiology and clinical features of facial cellulitis: a prospective study. Infect Dis 2018; 50(1): 27-34. https://doi.org/10.1080/23744235.2017.1354130
Amer M, Amer A. Rarely seen infections. Clin Dermatol 2014; 32(6): 744-51. https://doi.org/10.1016/j.clindermatol.2014.02.013
Mochizuki M, Mishimagi T, Sonoda I, Sato Y, Arai N, Amagasa T. A case of facial erysipelas which caused by odontogenic infection. Oral Therapeutics and Pharmacology 2008; 27(2): 131-5.
Raff AB, Kroshinsky D. Cellulitis. A review. JAMA 2016; 316(3): 325-37. https://doi.org/10.1001/jama.2016.8825
Gathsé A, Obengui, Ntsiba H. Etude rétrospective de 53 érysipèles hospitalisés au CHU de Brazzaville, Congo. Bull Soc Path Exo 2006; 99(1): 3-4. https://doi.org/10.3185/pathexo2727
Itiere Odzili FA, Mahoungou Guimbi K, Boumandoki PJC, Otiobanda GF, Ovoundard M, Ondzotto G. 67 cas de cellulite cervico-faciale, pris en charge sous anesthésie locale au CHUB de Brazzaville. Rev Stomatol Chir Maxillo-Faciale Chir Orale 2014; 115: 349-52. https://doi.org/10.1016/j.revsto.2014.10.010
Larivière D, Blavot-Delépine A, Fantin B, Lefort A. Survey of general practitioners management of erysipelas. Rev Med Interne 2011; 32: 730-5. https://doi.org/10.1016/j.revmed.2011.07.004
Sondo KA, Diendéré EA, Ouédraogo MS, Ouédraogo GA, Diallo I, Zoungrana J. Management of necrotizing and non-necrotic bacterial erysipelas of the face in tropical areas: a series of four cases and a review of the literature. Med Sante Trop 2018; 28: 273-76. https://doi.org/10.1684/mst.2018.0816
Fokina EG. Some features of primary facial erysipelas under the present conditions. Ter Arkr 2014: 86(11): 70-7.
Piso JR, Pop R, Wieland M, Griesshammer I, Urfer M, Schibli U, Bassetti S. Low sensitivity of needle aspiration cultures in patients with cellulitis/erysipelas. Springer Plus 2016; 5: 1578. https://doi.org/10.1186/s40064-016-3293-z
Brindle R, Williams M, Barton E, Featherstone P. Assessment of Antibiotic Treatment of Cellulitis and Erysipelas A Systematic Review and Meta-analysis. JAMA Dermatology 2019; 155(9): 1033-40. https://doi.org/10.1001/jamadermatol.2019.0884
